Navigation Links
'Mismatched' prostate cancer treatment more common than expected
Date:11/25/2007

More than a third of men with early prostate cancer who participated in a study analyzing treatment choice received therapies that might not be appropriate, based on pre-existing problems with urinary, bowel or sexual function. The prevalence of these treatment mismatches could reflect patient unwillingness to discuss such problems with their physicians. The study will appear in the January 1, 2007 issue of the journal Cancer and is being released online.

Prostate cancer patients experience the same fears and hard decisions as all cancer patients do, but prostate cancer treatment directly affects very personal things that most people aren't comfortable talking about urinary, bowel and sexual function, says James Talcott, MD, SM, of the Center for Outcomes Research at Massachusetts General Hospital (MGH) Cancer Center, who led the study. In this case, however, having that information matters because the three major treatments available to patients have different patterns of potential side effects. Knowing if patients already have problems in these areas should help guide treatment decisions.

The standard treatment options for early prostate cancer are external radiation therapy; brachytherapy, in which tiny radioactive particles are implanted into the prostate gland; and prostatectomy, surgical removal of the prostate gland. These approaches have similar levels of effectiveness, but each presents a different risk of side effects external radiation can lead to bowel dysfunction, brachytherapy may cause urinary problems, and surgery can damage nerves involved in sexual function. For patients who already have problems in these areas, therapies that could worsen their symptoms are usually not recommended. In addition, approaches designed to preserve normal functions, such as nerve-sparing prostate-removal surgery, would not be appropriate for patients for whom those functions have already been lost.

To investigate the frequency
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...play a major role in determining who succeeds in m... in the November issue of the Journal of Applied ...of Minnesota psychology professor Deniz Ones, foll...their seven-year medical school career, investigat...earning and performance in general. , During the...
(Date:12/3/2009)... year, editors of the Harvard Health Letter, in co..., choose the top 10 health stories of the year. He... Boston (Vocus) December 3,... Letter , in consultation with the doctors on its ...of the year. Here are four of the items on the lis...
(Date:12/3/2009)...sidue in those who rise and smoke, , , ... cigarette first thing in the morning? If so, take...d smoke inhale more nicotine than other smokers. ,...f the researchers said he thinks it could be a sig... drags on their cigarettes. And that, he said, cou...
(Date:12/3/2009)...a Pharma will be conducting a webinar on December ...counter and prescription treatments for chronic pa... Plantation, FL (Vocus) December 3, 2009 -- N...ompany that is developing treatments for Adrenomye...), has announced today that it will be hosting an ...
(Date:12/3/2009)... Deeper Look Educates Americans About This Grow...ges ,, DETROIT, Dec. 3 /PRNewswire-USNewswire...ith diabetes every 21 seconds. On December 5, 2009... exhibit, Diabetes: A Deeper Look, to help answe...tes, diabetes treatment and the role insulin plays...
Breaking Medicine News(10 mins):Health News:Personality predicts success in medical school, says new study by U of Minnesota professor 2Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 2Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 3Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 4Health News:Early Morning Smokers May Be More Dependent on Nicotine 2Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 2Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 2Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 4
...ept. 18 The U.S. Agency for,International Develop...assistant administrator of the Bureau for Democrac...ing to Zimbabwe, South Africa, Lesotho,and Madagas...racy and Governance., Hess,s regional trip will f...
...t. 18 Siemens Corporation, a,wholly owned subsidi...at the,statutory waiting period under the Hart-Sco...mended, applicable to its cash tender offer for al....com/cgi-bin/prnh/20070904/SIEMENSLOGO ) Siemens...
... of powdered energy drink mix category set to reac...es this year, MILL CREEK, Wash., Sept. 18 Zipfiz... than $30 million of its line of healthy,all-natur...its product line and launched its first TV adverti...
...., Sept. 18 Oakwood Southshore,Medical Center (OS...re,Promise," thanks to a generous gift from Anthon...ently to support the downriver hospital., "The So...n the business of saving and changing lives, and,t...
...Calif. - Despite the huge publicity generated by a...erapy for postmenopausal women, new research from ...hat only 29 percent of women surveyed knew about t... percent of the time. , Senior author Randall Sta...
... N.Y., Sept. 18 Six exceptional,registered nurses...Dimes,for graduate studies in the field of materna...amples of the dedication and vision of,nurses all ...p them go on to make even greater contributions to...
Other Medicine News:Health News:USAID Assistant Administrator Hess Travels to Southern Africa 2Health News:Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved 2Health News:Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved 3Health News:Zipfizz(R) Blows Away Competition 2Health News:$1 Million Gift Boosts Downriver Community 2Health News:Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds 2Health News:Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds 3Health News:March of Dimes Announces Nursing Scholarships 2
(Date:12/3/2009)... , WALTHAM, Mass., Dec. 3 /PRNewswire/ -... research and advisory firms focusing on pharmaceu...pe 2 diabetes drug market in Brazil will grow from... projected 15 percent annual growth rate is attrib...ation, increased use of new generation antidiabeti...
(Date:12/3/2009)... , SEELZE, Germany, Dec. 3 ...ear distribution agreement with Pro-Lab Laboratuar...Burdick & Jackson® high-purity solvents i... used extensively by biotechnology and pharmaceuti... process. ,, "The annual growth rate of the Tur...
(Date:12/3/2009)... , JERSUSALEM and NEEDHAM, Massachusetts, ...ms Ltd. (SIX Swiss Exchange: ORIDN) today announce...R) portable capnographs for its RTW (Rettungswagen...p paramedic teams to assess the ventilation status... affect respiratory status such as displaced endot...
Breaking Medicine Technology:Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4Washington Lupus Chapter Celebrates 35th Anniversary on December 5 61995 1Washington Lupus Chapter Celebrates 35th Anniversary on December 5 61995 2Drug ads ineffective for boosting sales could cost taxpayers 3A UBC Harvard study 61994 1Drug ads ineffective for boosting sales could cost taxpayers 3A UBC Harvard study 61994 2The cause behind the characteristic shape of a long leaf revealed 10881 1The cause behind the characteristic shape of a long leaf revealed 10881 2
...ive studies will use HistoRx AQUA(R)-based assays ...rs for predicting treatment response ...Conn., Sept. 4 HistoRx, Inc., announced,today tha...h the Radiation,Therapy Oncology Group (RTOG), a N...ve group. Under the terms of the agreement, HistoR...
...s Two Drugs From Its Metabolic Disease Program In ... CARLSBAD, Calif., Sept. 4 Isis,Pharmaceuticals,...iated a,Phase 1 study of ISIS 325568, an antisense... patients with type 2 diabetes by inhibiting produ...eceptor that binds glucagon, a,hormone that oppose...
Other Medicine Technology:HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 2HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 3Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes 2Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes 3
ART 250E
... Tips for its full line of 96- and 384-channel dis...lity, PerkinElmer Robotic Certified Tips are speci...n high throughput applications. Tips for 96-channe... 0.5 L to 235 L. Tips for 384-channel pipettors ar...
...oth regular and filter tips. Sterilized Diamond Ti... sterilization and are delivered with a certificat...tion. Sterilized Diamond Tips are ready to useprac...ps are wrapped in medical device quality plastic, ...
ART 180GGenomic Tip
Medicine Products: